<p>The emergence of artificial intelligence in protein structure prediction has significantly advanced our understanding of protein folding. Yet, challenges remain in accurately modeling intrinsically disordered proteins (IDPs) and capturing conformational diversity essential for drug discovery. FiveFold is a novel ensemble method that combines predictions from five complementary algorithms (AlphaFold2, RoseTTAFold, OmegaFold, ESMFold, and EMBER3D) to improve our understanding of protein conformational landscapes, representing a significant advancement in structural biology. This review examines current applications of the methodology, analyzes its unique advantages in modeling IDPs, and explores its expanding potential in drug discovery. To demonstrate the utility of this method, we conducted computational modeling of alpha-synuclein as a model IDP system, proving it can better capture conformational diversity than traditional single-structure methods. We discuss future applications in structure-based drug design, allosteric drug discovery, protein–protein interaction inhibitors, and precision medicine. The framework’s ability to generate multiple plausible conformations through its Protein Folding Shape Code (PFSC) and Protein Folding Variation Matrix (PFVM) addresses critical limitations in current structure prediction methodologies, enabling novel therapeutic intervention strategies targeting previously “undruggable” proteins.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A comprehensive application of FiveFold for conformation ensemble-based protein structure prediction

  • Sarfaraz K. Niazi,
  • Jiaan Yang

摘要

The emergence of artificial intelligence in protein structure prediction has significantly advanced our understanding of protein folding. Yet, challenges remain in accurately modeling intrinsically disordered proteins (IDPs) and capturing conformational diversity essential for drug discovery. FiveFold is a novel ensemble method that combines predictions from five complementary algorithms (AlphaFold2, RoseTTAFold, OmegaFold, ESMFold, and EMBER3D) to improve our understanding of protein conformational landscapes, representing a significant advancement in structural biology. This review examines current applications of the methodology, analyzes its unique advantages in modeling IDPs, and explores its expanding potential in drug discovery. To demonstrate the utility of this method, we conducted computational modeling of alpha-synuclein as a model IDP system, proving it can better capture conformational diversity than traditional single-structure methods. We discuss future applications in structure-based drug design, allosteric drug discovery, protein–protein interaction inhibitors, and precision medicine. The framework’s ability to generate multiple plausible conformations through its Protein Folding Shape Code (PFSC) and Protein Folding Variation Matrix (PFVM) addresses critical limitations in current structure prediction methodologies, enabling novel therapeutic intervention strategies targeting previously “undruggable” proteins.